Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice
J R Roubinian, N Talal, J S Greenspan, J R Goodman, P K Siiteri, J R Roubinian, N Talal, J S Greenspan, J R Goodman, P K Siiteri
Abstract
NZB/NZW F1 mice of both sexes were castrated at 2 wk of age and implanted subcutaneously with silastic tubes containing either 5-alpha-dihydrotestosterone or estradiol-17-beta. Mice receiving androgen showed improved survival, reduced anti-nucleic acid antibodies, or less evidence of glomerulonephritis as determined by light, immunofluorescent, and electron microscopy. By contrast, opposite effects were observed in castrated mice receiving estrogen. Intact male NZB/NZW F1 mice received androgen implants at 8 mo, an age when they develop an accelerated autoimmune disease associated with a decline in serum testosterone concentration. Such treated mice had improved survival and reduced concentrations of antibodies to DNA and to polyadenylic acid (Poly A). Prepubertal castration of male NZB/NZW F1 mice results in an earlier appearance of IgG antibodies to Poly A. This effect of castration was prevented if neonatal thymectomy was also performed.
References
- Immunology. 1977 Jan;32(1):75-9
- Arthritis Rheum. 1977 Jan-Feb;20(1):18-22
- J Immunol. 1977 May;118(5):1524-9
- J Clin Invest. 1977 Jun;59(6):1066-70
- Transplant Rev. 1976;32:140-67
- J Exp Med. 1972 Nov 1;136(5):1098-116
- Arthritis Rheum. 1970 Nov-Dec;13(6):887-94
- J Immunol. 1974 Nov;113(5):1438-45
- J Exp Med. 1968 Mar 1;127(3):507-22
- Am J Clin Pathol. 1974 Aug;62(2):258-80
- Cell Immunol. 1975 Dec;20(2):315-26
- Br J Urol. 1975 Feb;47(1):89-95
- Arthritis Rheum. 1973 Nov-Dec;16(6):719-25
- Blood. 1970 Mar;35(3):257-71
- Adv Immunol. 1968;9:215-66
- Transplant Rev. 1976;31:240-63
- J Reticuloendothel Soc. 1976 Jul;20(1):1-10
- Arthritis Rheum. 1969 Jun;12(3):241-6
- Proc Soc Exp Biol Med. 1968 Mar;127(3):664-7
- Am J Pathol. 1965 Oct;47(4):677-94
Source: PubMed